Did you attend this year’s meeting in Barcelona? * Yes No Please rate the extent to which each of the following learning objectives were met. * Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5= Strongly agree 12345 Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics. Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics. - 1 Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics. - 2 Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics. - 3 Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics. - 4 Review emerging clinical science presented at ECTRIMS 2015, including the neurodegenerative and inflammatory processes of multiple sclerosis, and the role of targeted therapeutics. - 5 Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis. Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis. - 1 Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis. - 2 Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis. - 3 Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis. - 4 Evaluate strategies presented at ECTRIMS 2015 to develop personalized treatment plans to effectively address treatment barriers for patients with multiple sclerosis. - 5 How many patients with multiple sclerosis do you see each month? * 0 1-10 11-20 21-30 31-40 41-50 51-60 >60 N/A: I don't see any patients. After participating in this activity, please rate your confidence in the following. * Please use the scale: 1=NOT at all confident, 2=Somewhat confident, 3=Confident, 4=Very confident, 5=EXTREMELY confident 12345 Your ability to identify and address treatment barriers when managing patients with multiple sclerosis? Your ability to identify and address treatment barriers when managing patients with multiple sclerosis? - 1 Your ability to identify and address treatment barriers when managing patients with multiple sclerosis? - 2 Your ability to identify and address treatment barriers when managing patients with multiple sclerosis? - 3 Your ability to identify and address treatment barriers when managing patients with multiple sclerosis? - 4 Your ability to identify and address treatment barriers when managing patients with multiple sclerosis? - 5 Your understanding of the science of B-cell targeted therapy in multiple sclerosis? Your understanding of the science of B-cell targeted therapy in multiple sclerosis? - 1 Your understanding of the science of B-cell targeted therapy in multiple sclerosis? - 2 Your understanding of the science of B-cell targeted therapy in multiple sclerosis? - 3 Your understanding of the science of B-cell targeted therapy in multiple sclerosis? - 4 Your understanding of the science of B-cell targeted therapy in multiple sclerosis? - 5 As a result of participating in this activity, I will consider current clinical trial data on therapeutic targets to improve outcomes of patients with multiple sclerosis. * Yes No Please take a moment to reflect on your current use of the practice strategies discussed in this activity. You will not be graded on your responses. Indicate how often you PLAN TO use each of the following clinical practice strategies for your patients with multiple sclerosis. * Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable to me 12345N/A Communicate treatment barriers to patients and develop personalized treatment plans. Communicate treatment barriers to patients and develop personalized treatment plans. - 1 Communicate treatment barriers to patients and develop personalized treatment plans. - 2 Communicate treatment barriers to patients and develop personalized treatment plans. - 3 Communicate treatment barriers to patients and develop personalized treatment plans. - 4 Communicate treatment barriers to patients and develop personalized treatment plans. - 5 Communicate treatment barriers to patients and develop personalized treatment plans. - N/A Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. - 1 Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. - 2 Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. - 3 Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. - 4 Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. - 5 Understand the neurodegenerative and inflammatory process of MS, as well as emerging therapeutic options, such as B-cell targeted therapies. - N/A Do you feel the activity was fair, balanced, and free of commercial bias? * Yes No If No, please explain What topics would you like to see in future CME activities? Do you wish to be notified by email when new educational programs are offered by Elsevier? Yes No Leave this field blank
